1M14
Tyrosine Kinase Domain from Epidermal Growth Factor Receptor
1M14 の概要
エントリーDOI | 10.2210/pdb1m14/pdb |
関連するPDBエントリー | 1M17 |
分子名称 | Epidermal growth factor receptor (2 entities in total) |
機能のキーワード | transferase, tyrosine kinase domain |
由来する生物種 | Homo sapiens (human) |
細胞内の位置 | Cell membrane; Single-pass type I membrane protein. Isoform 2: Secreted: P00533 |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 37875.75 |
構造登録者 | |
主引用文献 | Stamos, J.,Sliwkowski, M.X.,Eigenbrot, C. Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor. J.Biol.Chem., 277:46265-46272, 2002 Cited by PubMed Abstract: The crystal structure of the kinase domain from the epidermal growth factor receptor (EGFRK) including forty amino acids from the carboxyl-terminal tail has been determined to 2.6-A resolution, both with and without an EGFRK-specific inhibitor currently in Phase III clinical trials as an anti-cancer agent, erlotinib (OSI-774, CP-358,774, Tarceva(TM)). The EGFR family members are distinguished from all other known receptor tyrosine kinases in possessing constitutive kinase activity without a phosphorylation event within their kinase domains. Despite its lack of phosphorylation, we find that the EGFRK activation loop adopts a conformation similar to that of the phosphorylated active form of the kinase domain from the insulin receptor. Surprisingly, key residues of a putative dimerization motif lying between the EGFRK domain and carboxyl-terminal substrate docking sites are found in close contact with the kinase domain. Significant intermolecular contacts involving the carboxyl-terminal tail are discussed with respect to receptor oligomerization. PubMed: 12196540DOI: 10.1074/jbc.M207135200 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.6 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード